PharmaCivica Rx to Supply California's $30 Insulin
CalRx will offer biosimilars for Glargine, Aspart, and Lispro, which are expected to be interchangeable with Lantus, Humalog, and Novolog...
PharmaIRA-mandated Free Vax Could Save Seniors More Than $230M
As of January 1, vaccines are now free under Medicare Part D, and include vaccines for Tdap and shingles.
TechnologyHow Providers Should Use Technology to Meet the EPCS Mandate
Digital health tools that allow providers to electronically prescribe controlled medications can improve care management and curb drug misuse if...
PharmaDaré Bioscience CEO Drives Culture of Transformation in Women's Health
The company prioritizes unmet needs for women in contraception, fertility, and vaginal and sexual health.
PayerA Bitter Battle Over the 'Orphan Drug' Program Leaves Patients' Pocketbooks at Risk
Millions of Americans with rare diseases are caught up in an ongoing legal and political debate about how the U.S....
PharmaCMS Rolls Out 3 Medicare Drug Savings Models
The models were authorized under an executive order by President Joe Biden to 'complement' drug cost-savings provisions in the Inflation...
PharmaCMS Unveils Guidance, Timeline for Medicare Drug Inflation Rebates
Feds want public input on key provisions, including how to impose civil monetary penalties on drugmakers.
PharmaDecisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Consolidations by CVS and Optum Rx left thousands without essential drugs and nutrients.
PharmaPharma Spends More On Ads Pushing Low-Value Drugs
A new study highlights the complex dynamic between consumer advertising for prescription drugs and patients and clinicians.
PharmaAmazon Pharmacy Launches Very, Very Low-Cost Prescription Drug Service
RxPass will cost $5 a month for an unlimted supply of ALL commonly used drugs in its generic and off-brand...
Supply ChainFDA eases outsourcing facility ibuprofen compounding for hospitals
To help hospitals and health systems meet demand during the current surge in respiratory illnesses for fever-reducing products to treat...
PharmaFDA Rejects Fast-Track Approval of Eli Lilly's New Alzheimer's Drug
Regulators want more evidence that the pricey drug works.